Claude Bernard-Horner syndrome represents a classic clinical triad—miosis, ptosis, and anhidrosis—that serves as a critical diagnostic window into the sympathetic nervous system. While often referred to simply as Horner syndrome in English-speaking medical circles, the full name honors both the French physiologist Claude Bernard, who first described the condition's experimental basis in 1852, and the Swiss ophthalmologist Johann Friedrich Horner, who provided the first definitive clinical description in 1869. Understanding this syndrome requires a deep dive into the complex anatomical highway that connects the brain to the eye.

The fundamental triad of symptoms

The clinical presentation of Claude Bernard-Horner syndrome is characterized by a disruption in the oculosympathetic pathway. This pathway is responsible for the "fight or flight" responses in the eye and face. When this circuit is broken at any point, three primary signs emerge on the same side as the lesion (ipsilateral).

Miosis: The constricted pupil

The pupil on the affected side appears smaller than the one on the healthy side (anisocoria). This occurs because the iris dilator muscle, which is controlled by sympathetic fibers, can no longer counteract the parasympathetic-driven iris sphincter muscle. A key diagnostic feature is "dilation lag": when the lights are dimmed, the affected pupil dilates much more slowly than the normal one, reaching its final size after 15 to 20 seconds.

Ptosis: The drooping eyelid

The sympathetic nervous system innervates the superior tarsal muscle (Müller's muscle), which provides an additional 1-2 millimeters of eyelid elevation. When these nerves fail, the upper eyelid droops slightly. Unlike the severe ptosis seen in third cranial nerve palsy, the ptosis in Claude Bernard-Horner syndrome is mild. Interestingly, it often presents with "upside-down ptosis," where the lower eyelid sits slightly higher than normal due to denervation of the inferior tarsal muscle.

Anhidrosis: The lack of sweating

The loss of sweating on the face and neck is a variable sign depending on where the nerve damage occurs. Because the sweat glands are also supplied by sympathetic fibers, their failure results in dry, flushed skin. The specific pattern of anhidrosis helps clinicians localize whether the problem is in the brain, the chest, or near the carotid artery.

The three-neuron pathway: Mapping the disruption

To understand why a problem in the lung or the neck can affect the eye, one must trace the long, convoluted path of the oculosympathetic nerves. This journey is divided into three distinct segments, or neurons.

The first-order (Central) neuron

The journey begins in the posterolateral hypothalamus. These fibers descend through the brainstem (midbrain, pons, and medulla) and terminate in the intermediolateral gray column of the spinal cord at the C8 to T2 levels. This specific area of the spinal cord is known as the Ciliospinal Center of Budge.

Disruptions here are often caused by central nervous system issues. For instance, a stroke in the lateral medulla—known as Wallenberg syndrome—is a frequent cause of central Horner syndrome. Patients in these cases may also experience vertigo, difficulty swallowing, or a loss of pain sensation on the opposite side of the body.

The second-order (Preganglionic) neuron

Fibers exit the spinal cord at the T1 level and travel over the apex (top) of the lung. They then ascend through the cervical sympathetic chain to the superior cervical ganglion, located near the angle of the jaw and the bifurcation of the common carotid artery.

Because this segment passes so close to the lungs and the large vessels of the chest, it is highly susceptible to thoracic pathologies. A Pancoast tumor, which is a type of lung cancer at the very top of the lung, can compress these nerves, making Horner syndrome one of the first signs of an underlying malignancy.

The third-order (Postganglionic) neuron

The final segment begins at the superior cervical ganglion. These fibers hitch a ride on the wall of the internal carotid artery to enter the skull. They pass through the cavernous sinus and eventually reach the iris dilator muscle and Müller’s muscle via the long ciliary nerves.

Crucially, the fibers responsible for facial sweating branch off earlier, following the external carotid artery. Therefore, a lesion in this third-order segment (such as a carotid artery dissection) typically does not cause anhidrosis of the entire face, though it may cause sweating loss specifically above the eyebrow.

Critical causes and clinical significance

Claude Bernard-Horner syndrome is rarely a disease in itself; rather, it is a signal of an underlying condition. The urgency of the diagnosis depends heavily on the associated symptoms and the localization of the lesion.

Carotid artery dissection

A painful Horner syndrome is considered a medical emergency until proven otherwise. If a patient experiences a sudden onset of ptosis and miosis accompanied by neck pain or a headache, it strongly suggests a tear in the wall of the internal carotid artery (dissection). This can lead to a stroke if not treated immediately. The pain is often described as a constant ache behind the eye or along the side of the neck.

Pancoast tumors and thoracic issues

When the syndrome is localized to the second-order neuron, clinicians look closely at the chest and neck. Aside from lung tumors, other causes include cervical ribs (extra ribs that can compress nerves), thoracic aortic aneurysms, or trauma from surgeries like thyroidectomies or neck dissections.

Pediatric implications

In children, the syndrome can be congenital (present at birth) or acquired. Congenital Horner syndrome often presents with heterochromia iridis—a difference in eye color between the two eyes. This happens because the sympathetic nerves are necessary for the development of melanin in the iris during the first two years of life. The affected eye remains lighter (usually blue or gray) while the normal eye turns brown or green. A common cause in infants is birth trauma affecting the brachial plexus.

Diagnostic procedures: Beyond the naked eye

Confirming the presence of Claude Bernard-Horner syndrome and determining its location often involves specialized pharmacological testing. While imaging like MRI and CT is the gold standard for finding the cause, eye drops are used to confirm the nerve deficit.

The Apraclonidine test

Apraclonidine is an alpha-adrenergic agonist. In a healthy eye, it has little effect on pupil size. However, in an eye with Horner syndrome, the iris dilator muscle becomes hypersensitive to adrenergic stimulation (denervation supersensitivity). When the drops are applied, the affected pupil dilates and the ptosis often improves, while the normal pupil remains unchanged. This "reverses" the anisocoria, confirming the diagnosis.

The Cocaine test

Historically, cocaine drops were used as the definitive test. Cocaine prevents the reuptake of norepinephrine at the nerve endings. If the nerves are damaged, there is no norepinephrine to begin with, so the affected pupil will not dilate. While effective, the legal and logistical challenges of using cocaine have made Apraclonidine the more common choice in modern clinics.

Localization with Hydroxyamphetamine

Once the syndrome is confirmed, hydroxyamphetamine drops can help distinguish between a preganglionic (second-order) and postganglionic (third-order) lesion. If the third-order neuron is intact, the drops will cause the pupil to dilate. If it is damaged, no dilation occurs. This helps the medical team decide whether to scan the chest or the head.

Modern imaging and management strategies

As of 2026, imaging protocols have become highly refined. For a patient presenting with an undifferentiated Claude Bernard-Horner syndrome, a comprehensive workup usually includes:

  1. MRI of the brain and neck: To look for brainstem strokes, demyelinating diseases like multiple sclerosis, or tumors.
  2. MRA or CTA of the neck: Specifically to visualize the carotid arteries and rule out dissection.
  3. CT of the chest: To inspect the lung apices and the mediastinum for any masses or vascular anomalies.

Management focuses entirely on treating the underlying cause. If the cause is a benign cluster headache, management is symptomatic. If it is a dissection, anticoagulation or antiplatelet therapy is often required. For tumors, oncology protocols are initiated. The eye symptoms themselves rarely require direct treatment, though some patients may opt for minor eyelid surgery if the ptosis is bothersome.

Prognosis and long-term outlook

The prognosis for someone with Claude Bernard-Horner syndrome depends exclusively on the primary pathology. The nerve damage itself is often permanent if the underlying cause is not reversed quickly, but the miosis and ptosis are generally stable and do not lead to vision loss. The primary value of identifying this syndrome remains its role as a "red flag" for systemic or neurological conditions that might otherwise go unnoticed.

In clinical practice, the discovery of a small pupil and a slightly droopy lid is the beginning of a diagnostic journey. It requires a meticulous approach, considering the entirety of the patient's history—from recent neck trauma to a chronic cough. By respecting the anatomical logic of the three-neuron pathway, healthcare providers can navigate the complexities of the syndrome to reach an accurate and potentially life-saving diagnosis.

Summary of key takeaways

  • The Triad: Miosis (small pupil), Ptosis (droopy lid), and Anhidrosis (dry skin) are the hallmarks.
  • The Pathway: The syndrome can be caused by a lesion anywhere from the hypothalamus to the eye.
  • Emergency Signs: A sudden, painful Horner syndrome suggests a carotid artery dissection.
  • Pediatric Signs: Different colored eyes (heterochromia) in a child can indicate a congenital sympathetic nerve issue.
  • Diagnostic Tools: Apraclonidine and advanced imaging are essential for confirming and localizing the damage.

Claude Bernard-Horner syndrome stands as a testament to the interconnectedness of the human body. A tiny change in the eye can be the first whisper of a story unfolding deep within the chest or the brain, making it one of the most significant clinical observations in neurology and ophthalmology.